期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Reporting and understanding the safety and adverse effect profile of mobile apps for psychosocial interventions:An update 被引量:3
1
作者 Farooq Naeem Nadeem Gire +5 位作者 Shuo Xiang Megan Yang Yumeen Syed Farhad Shokraneh clive adams Saeed Farooq 《World Journal of Psychiatry》 SCIE 2016年第2期187-191,共5页
Recent years have seen a rapidly increasing trend towards the delivery of health technology through mobile devices.Smartphones and tablet devices are thus becoming increasingly popular for accessing information and a ... Recent years have seen a rapidly increasing trend towards the delivery of health technology through mobile devices.Smartphones and tablet devices are thus becoming increasingly popular for accessing information and a wide range of services,including health care services.Modern mobile apps can be used for a variety of reasons,ranging from education for the patients and assistance to clinicians to delivery of interventions.Mobile phone apps have also been established to benefit patients in a scope of interventions across numerous medical specialties and treatment modalities.Medical apps have their advantages and disadvantages.It is important that clinicians have access to knowledge to make decisions regarding the use of medical apps on the basis of risk-benefit ratio.Mobile apps that deliver psycho social interventions offer unique challenges and opportunities.A number of reviews have highlighted the potential use of such apps.There is a need to describe,report and study their side effects too.The adverse effects associated with these apps can broadly be divided into:(1)those resulting from the security and safety concerns;(2)those arising from the use of a particular psycho social intervention;and(3)those due to the interaction with digital technology.There is a need to refine and reconsider the safety and adverse effects in this area.The safety profile of a mobile PSI app should describe its safety profile in:(1)privacy and security;(2)adverse effects of psychotherapy;and(3)adverse effects unique to the use of apps and the internet.This is,however,a very new area and further research and reporting is required to inform clinical decision making. 展开更多
关键词 MOBILE Psycho social Side effects Health Media Security PRIVACY
暂未订购
Rapid Tranquillisation: An AGREEable Ground?
2
作者 Pallavi Nadkarni Mahesh Jayaram +2 位作者 Shailesh Nadkarni Ranga Rattehalli clive adams 《Open Journal of Psychiatry》 2014年第3期269-274,共6页
Objective: Evidence base for rapid tranquillisation is an under researched area. Guidelines on rapid tranquilisation from English speaking countries were appraised using AGREE (Appraisal of Guidelines Research and Eva... Objective: Evidence base for rapid tranquillisation is an under researched area. Guidelines on rapid tranquilisation from English speaking countries were appraised using AGREE (Appraisal of Guidelines Research and Evaluation) and differences in their recommendations were analysed. Methods: Four independent psychiatrists appraised the guidelines using the AGREE tool. AGREE is a validated instrument used to assess the quality of guideline and recommendations using six domains of which each domain captures a specific aspect of the guideline development. The content was analysed manually. Results: Seven guidelines from five English speaking countries met the inclusion criteria. All the guidelines scored well on the domain of “scope and purpose”. NICE guidelines from the UK consistently scored well on all domains with the maximum possible score of 100 on the “applicability” domain. APA from the USA did well on the domain of “editorial independence”. AGREE could only examine the guideline development process and not the content. The guidelines differed in their recommendations of choice of drug for rapid tranquillisation. Discussion: All guidelines scored reasonably well on AGREE. National Institute of Clinical Excellence (NICE) has used robust strategies in developing the guidelines. Guidelines failed to achieve consensus in recommendations despite using a common pool of evidence. Haloperidol-promethazine combination is not recommended by any with the exception of NICE. This suggests data is selectively interpreted depending on locally prevalent customs. 展开更多
关键词 Tranquillisation GUIDELINES Anti-Psychotics PSYCHIATRIC EMERGENCIES
暂未订购
Cochrane及其他系统评价中"无差异"或"无效"声明的意义 被引量:1
3
作者 Phoebe Rose Marson Smith Lynda Ware +2 位作者 clive adams Iain Chalmers 孟玲慧(译) 《英国医学杂志中文版》 2020年第8期459-461,共3页
由于数据质量和机会抽样的影响,通过与对照组比较获得的对治疗效果/差异的估计存在不确定性。尽管如此,有时作者仍然会使用统计学显著性检验做出明确的陈述,即治疗之间"无差异"。2001/2002年发表了一项评估Cochrane系统评价... 由于数据质量和机会抽样的影响,通过与对照组比较获得的对治疗效果/差异的估计存在不确定性。尽管如此,有时作者仍然会使用统计学显著性检验做出明确的陈述,即治疗之间"无差异"。2001/2002年发表了一项评估Cochrane系统评价摘要的调查,1 212篇系统评价摘要中有259篇(21.3%)对"无差异"或"无效"提出了错误的声明。我们重复了这一调查,以评估2017年已发表的Cochrane及其他系统评价摘要中此类声明的频率。共调查2017年发表的Cochrane系统评价摘要和其他系统评价摘要中各643项随机研究,剔除仅涉及研究方案、缺少结论或不包含任何结论相关信息的系统评价摘要。调查过程中采取了减少偏倚的措施。声明为"无差异/无效"者,在460篇Cochrane系统评价摘要中有36篇(7.8%),218篇其他系统评价摘要中有13篇(6.0%)。在2017年发表的Cochrane系统评价中,"无差异/无效"的错误声明比2001/2002年发表的系统评价摘要中有实质性减少。我们希望这反映出2017年的调查为减少偏见和不一致的判断而做出了更大努力,以及对摘要措辞的审阅更加谨慎。对效果的陈述还有许多其他方式的错误,这些问题也必须加以解决,因为它们对卫生和健康研究会产生不利影响。 展开更多
关键词 调查过程 随机研究 统计学显著性 COCHRANE 数据质量 卫生和健康 声明
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部